PhysIOL Announces Full Ownership of Optikon

Source: PhysIOL

After the acquisition of a majority stake in the Italian company Optikon on September 17, 2017, PhysIOL announced that it has completed the acquisition of the minority shares, leading to an 100% ownership of Optikon.

Terms of the deal were not disclosed.

Italy-based Optikon develops and markets ophthalmic devices, including phaco, vitrectomy, and diagnostic equipment. Optikon’s product portfolio includes the R-Evolution and Pulsar machines.


Related Content